Cann Group (ASX:CAN) Common Stock: A$197.32 Mil (As of Dec. 2025)


What is Cann Group Common Stock?

Cann Group ASX:CAN Common Stock is A$197.32 Mil as of Dec. 2025. The stock has 7 warning signs investors should review.

Cann Group's quarterly common stock increased from Dec. 2024 (A$186.16 Mil) to Jun. 2025 (A$187.95 Mil) and increased from Jun. 2025 (A$187.95 Mil) to Dec. 2025 (A$197.32 Mil).

Cann Group's annual common stock increased from Jun. 2023 (A$177.37 Mil) to Jun. 2024 (A$182.90 Mil) and increased from Jun. 2024 (A$182.90 Mil) to Jun. 2025 (A$187.95 Mil).

Cann Group Common Stock Historical Data

* Premium members only.

The historical data trend for Cann Group's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cann Group Common Stock Chart

Cann Group Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
Get a 7-Day Free Trial Premium Member Only 149.67 169.43 177.37 182.90 187.95

Cann Group Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 182.38 182.90 186.16 187.95 197.32

Cann Group Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$197.32 Mil mean?
Cann Group (ASX:CAN) has a Common Stock of A$197.32 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Cann Group and its competitors.
Is Cann Group's Common Stock too high?
Cann Group's current Common Stock is A$197.32 Mil.
How does Cann Group's Common Stock compare to ZTS?
Cann Group's Common Stock of A$197.32 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Cann Group and its competitors. Cann Group's current Common Stock is A$197.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cann Group stock overvalued right now?
Based on GuruFocus' analysis, Cann Group (ASX:CAN) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.00 — trading 85% below its estimated fair value. The current Common Stock is A$197.32 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Cann Group (ASX:CAN), the current Common Stock is A$197.32 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cann Group Business Description

Other Exchanges CNGGF:USA
Address 262-276 Lorimer Street, Ground Floor, Port Melbourne, VIC, AUS, 3207
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes under the licenses and permits issued to the company, the development and manufacture (via third-party arrangements) of finished product formulations. Geographically, the company operates in Europe and Australia. The company derives maximum revenue from Australia.